You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 20, 2025

Investigational Drug Information for Ciraparantag


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Ciraparantag?

Ciraparantag is an investigational drug.

There have been 4 clinical trials for Ciraparantag. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2020.

The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc., Perosphere, Inc., and [disabled in preview].

There are eight US patents protecting this investigational drug and eighty-nine international patents.

Recent Clinical Trials for Ciraparantag
TitleSponsorPhase
Study of Ciraparantag for Reversal of Anticoagulation Induced by Apixaban or Rivaroxaban in Healthy AdultsPerosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.Phase 2
Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCTPerosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.Phase 2
Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCTPerosphere, Inc.Phase 2

See all Ciraparantag clinical trials

Clinical Trial Summary for Ciraparantag

Top disease conditions for Ciraparantag
Top clinical trial sponsors for Ciraparantag

See all Ciraparantag clinical trials

US Patents for Ciraparantag

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ciraparantag ⤷  Try for Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try for Free
Ciraparantag ⤷  Try for Free Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) ⤷  Try for Free
Ciraparantag ⤷  Try for Free Ruthenium-sphingomyelin complexes and methods for their use in the treatment of tumors ⤷  Try for Free
Ciraparantag ⤷  Try for Free Anticoagulant reversal agents PEROSPHERE INC. (Danbury, CT) ⤷  Try for Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ciraparantag

Drugname Country Document Number Estimated Expiration Related US Patent
Ciraparantag Australia AU2016272089 2035-06-03 ⤷  Try for Free
Ciraparantag Canada CA2987114 2035-06-03 ⤷  Try for Free
Ciraparantag China CN106236715 2035-06-03 ⤷  Try for Free
Ciraparantag China CN108653221 2035-06-03 ⤷  Try for Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.